DANIELLE NORRIS: Open Payments
NPI 1225898190 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,770 in 82 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $873 · 2025 $1,770
Food & beverage: $1,719Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $373 |
| Janssen Biotech, Inc. | 18 | $296 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $290 |
| Madrigal Pharmaceuticals | 9 | $261 |
| Phathom Pharmaceuticals, Inc. | 5 | $173 |
| Aimmune Therapeutics, Inc. | 5 | $129 |
| Ardelyx, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Celltrion USA Inc. | 2 | $45 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, VOQUEZNA, RINVOQ, ZENPEP, LINZESS, CREON.
Industry payments across IN — which companies pay providers there.
